Efficacy of ivabradine in patients with poor heart rate control after beta-blocker use in acute myocardial infarction: a pragmatic randomized controlled trial
In "real-world" patients with AMI and poorly controlled heart rate despite titration of beta-blocker dosing, ivabradine was safe and effective in controlling heart rate and improving LVEF early after discharge. However, it had no effect on the 12-month incidence of hospitalization for heart failure and cardiovascular death after discharge.
Authors
- Ying Ren (ORCID: https://orcid.org/0000-0002-5427-5283)
- Lisong Cheng
- Jian Cui (ORCID: https://orcid.org/0000-0001-7677-9522)
- Wenting Li (ORCID: https://orcid.org/0000-0001-5288-8310)
- Yongbin Li (ORCID: https://orcid.org/0000-0003-1715-1131)
- Xin Zhou (ORCID: https://orcid.org/0009-0001-9321-3632)
- Zhuhua Yao (ORCID: https://orcid.org/0000-0002-6443-9616)
- Lingli Zhang (ORCID: https://orcid.org/0009-0003-4934-8374)
Institutions
- Nankai University (CN)
- Tianjin First Center Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-03
- DOI
- https://doi.org/10.3389/fcvm.2025.1560639
- Citations
- 1
- Primary Topic
- Heart rate and cardiovascular health
- Type
- article
- Field-Weighted Citation Impact
- 1.39